Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatment.
Grace Lai-Hung WongHenry Lik Yuen ChanYee-Kit TseTerry Cheuk-Fung YipKelvin Long-Yan LamGrace Chung-Yan LuiCheuk-Chun SzetoVincent Wai-Sun WongPublished in: Alimentary pharmacology & therapeutics (2018)
The use of TDF was associated with mild renal impairment in a minority of patients; those treated with ETV had a similar risk compared to untreated patients.